Showing results (321-330 of 463) with videos related to

Sort By:
Pageof 47
Stroke|July 30, 2016
Tumor-Like Presentation of Primary Angiitis of the Central Nervous SystemHubert de Boysson, Grégoire Boulouis, Nelly Dequatre, et al.
Rheumatology (Oxford, England)|March 25, 2017
Maintenance therapy is associated with better long-term outcomes in adult patients with primary angiitis of the central nervous systemHubert de Boysson, Jean-Jacques Parienti, Caroline Arquizan, et al.
Kidney International Reports|April 14, 2025
Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal CrisisAïcha Kante, Paul Legendre, Bérangère S Joly, et al.
Investigative Ophthalmology & Visual Science|August 19, 2016
Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment EpitheliumJared E Knickelbein, Baoying Liu, Anush Arakelyan, et al.
Medicine|March 21, 2014
Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow-up of 40 patientsAlexis Régent, Brigitte Autran, Guislaine Carcelain, et al.
Rheumatology (Oxford, England)|January 29, 2009
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie studyEric Hachulla, Patrick Carpentier, Virginie Gressin, et al.
Arthritis and Rheumatism|December 2, 2005
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter studyEric Hachulla, Virginie Gressin, Loïc Guillevin, et al.
Seminars in Arthritis and Rheumatism|October 15, 2013
Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: a retrospective multicenter studyJean-Christophe Lega, Raphaèle Seror, Thomas Fassier, et al.
Rheumatology (Oxford, England)|August 13, 2024
Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesionsNoémie Le Gouellec, Louai Zaidan, Benjamin Chaigne, et al.
JAMA Network Open|July 8, 2022
Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated VasculitisSara Thietart, Alexandre Karras, Jean-François Augusto, et al.
Pageof 47